Dr. Rathi Devi's book on menopause released

July 2, 2012

RB_1

Mangalore, July 2: More men than women should read the book on menopause as it will help them understand women better, especially when the latter are going through it, said Shahnaz, Chief Editor, Anupama Kannada monthly. She was speaking in the city on Sunday at an event to launch a book titled Muttina Mussanjeyalli.

Dr. Rathi Devi, Professor, Kasturba Medical College (KMC) and author of the book, said that women must go for annual medical checkups to prevent bigger problems later. The book tells readers how to manage the physical and health changes in women during menopause.

She said that women going through menopause might get irritable, angry, upset or cry over small things. It was a time when they felt that they were alienated and that their husbands and children did not care for them. For the husband and the family to understand women better when they were going through the phase, they must know about menopause and its effects on women, she said.

Ms. Shahnaz said that combining the study of medicine with writing was an unusual combination. Harikrishna Punaroor, former president of State Kannada Sahitya Parishat, who inaugurated the event, said that a person might have wealth but one could not buy health. He said that women, with ageing, had to counter a host of health issues with menopause.

Dr. Rathi Devi's mentor, Chakrapani Udupa, former principal of Poornaprajna Pre-University College, Admar, and his wife, Shakuntala, were felicitated.

K. Mohandas Bhandary, Vice-President, Indian Medical Association Karnataka Chapter, said 50 per cent of the patients did not need medicines and they just needed a good word told to them.

Dr. Shakunthala M.M., Medical Superintendent, Government Lady Goschen Hospital, said that Dr. Rathi Devi had become a doctor after facing several challenges and obstacles.

RB_2

RB_3

RB_4

RB_5

Comments

Rex
 - 
Tuesday, 5 Jan 2016

ouvrir
un compte: http://www.ouvrircompte.net dans une banque en ligne: http://www.banque.net banque en ligne: http://www.banqueenligne.eu et
voir les avis banque en ligne: http://www.avisbanque.net

http://www.avisbanque.net

http://www.banque.net

http://www.ouvrircompte.net

http://www.banqueenligne.eu

http://www.banque.net/banque-lcl/

http://www.ouvrircompte.net/revue-ouvrir-un-compte-lcl/

http://www.ouvrircompte.net/revue-ouvrir-un-compte-monabanq/

http://www.avisbanque.net/monabanq/

http://www.banque.net/banque-monabanq/

http://www.ouvrircompte.net/revue-ouvrir-un-compte-hello-bank/

http://www.banque.net/hello-bank/

http://www.avisbanque.net/hello-bank/

http://www.ouvrircompte.net/revue-ouvrir-un-compte-la-net-agence/

http://www.banque.net/banque-net-agence/

http://www.avisbanque.net/la-net-agence/

http://www.ouvrircompte.net/revue-ouvrir-un-compte-ing-direct/

http://www.banque.net/ing-direct/

http://www.avisbanque.net/ing-direct/

Faire le bon choix représente un véritable enjeu lorsque l’on souhaite ouvrir un nouveau compte en ligne : des centaines d’offres nous
sont proposées,
que ce soit à travers les emails, la publicité télévisée, ou encore les pages web
que l’on trouve sur Google suite à des recherches au sujet de comptes bancaires en ligne…
En d’autres termes, nous sommes véritablement submergés d’informations
et ne savons pas auprès de quel établissement ouvrir un compte en banque
en ligne.
Il est pourtant facile de faire le bon choix grâce aux avis des internautes que l’on peut facilement trouver sur le net.
En effet, ces avis sont généralement fiables et
objectifs étant donné qu’ils décrivent l’expérience réelle de l’utilisateur.

L’objectif de notre site s’inscrit dans la même démarche,
en visant à vous fournir un avis clair et précis, afin que vous puissiez ouvrir un compte bancaire sur
internet auprès d’une banque en ligne sérieuse et performante.

L’ensemble des banques en ligne de notre sélection sont
des banques sérieuses qui vous permettront d’ouvrir un compte bancaire en ligne
rapidement et simplement, en vous offrant des tarifs très compétitifs.
Toutefois, ces banques en ligne ne recouvrent pas toutes les mêmes

caractéristiques et conviendront donc à des clients de différents profils.

Si vous ne savez toujours pas auprès de quel établissement ouvrir un compte
en banque en ligne, n’hésitez pas à découvrir notre
analyse détaillée
sur chacune de ces banques, ou à vous rendre sur leur site
respectif, en cliquant sur les liens présents dans le tableau ci-dessus.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
June 9,2020

Bengaluru, Jun 9: The total number of positive COVID-19 cases in Karnataka rose to 5,921 on Tuesday after the state reported two deaths and 161 new cases of the virus.

"Two deaths and 161 new COVID-19 positive cases reported from yesterday 5 pm till today at 5 pm, taking the total number of positive cases to 5,921," said Karnataka Health Department.

The toll in the state is presently at 66.

While 164 patients have been discharged today, the number of discharged patients so far is 2,605. The active cases in the state stands at 3,248.

Among the new cases, Yadgir contributed highest (61), followed by Bengaluru Urban (29) and Dakshina Kannada (23). Udupi did not report any new case. More details to follow.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 20,2020

Udupi, Jun 20: The wife and daughter of a 54-year-old man who succumbed to Covid-19, tested positive for the virus on Saturday.

Sources said that the family returned to Udupi on June 18 and the man died the same day while his wife and daughter tested positive today.

The man and his family had arrived at their house in Thekkatte on Thursday, June 18 afternoon. Later in the day, the man died. He was suffering from jaundice and had arrived from Mumbai in the state of illness.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.